These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6612678)

  • 1. Evidence for appearance of "lysis independent" procoagulant activities in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1983 Jun; 30(5):449-58. PubMed ID: 6612678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet factor 3 assay and the availability of platelet factor 3 in collagen or thrombin stimulated platelets.
    Brox JH; Osterud B
    Thromb Res; 1984 Mar; 33(5):555. PubMed ID: 6719401
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3.
    Sandberg H; Bode AP; Dombrose FA; Hoechli M; Lentz BR
    Thromb Res; 1985 Jul; 39(1):63-79. PubMed ID: 3839944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.
    Tans G; Rosing J; Thomassen MC; Heeb MJ; Zwaal RF; Griffin JH
    Blood; 1991 Jun; 77(12):2641-8. PubMed ID: 2043766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.
    Bode AP; Sandberg H; Dombrose FA; Lentz BR
    Thromb Res; 1985 Jul; 39(1):49-61. PubMed ID: 3839943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the procoagulant activity of platelets stimulated by collagen and thrombin.
    Bevers EM; Comfurius P; Hemker HC; Zwaal RF
    Thromb Res; 1984 Mar; 33(5):553-4. PubMed ID: 6719400
    [No Abstract]   [Full Text] [Related]  

  • 7. Analysis of platelet factor 3 in platelet concentrates stored for transfusion.
    Bode AP; Miller DT
    Vox Sang; 1986; 51(4):299-305. PubMed ID: 3798864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen derived octapeptide inhibits platelet procoagulant activity induced by the combined action of collagen and thrombin.
    Bevers EM; Karniguian A; Legrand YJ; Zwaal RF
    Thromb Res; 1985 Feb; 37(3):365-70. PubMed ID: 3922080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet procoagulant properties studied with snake venom prothrombin activators.
    Speijer H; Govers-Riemslag JW; Zwaal RF; Rosing J
    Thromb Haemost; 1987 Jun; 57(3):349-55. PubMed ID: 3310319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor 1 is the primary mediator of thrombin-stimulated platelet procoagulant activity.
    Andersen H; Greenberg DL; Fujikawa K; Xu W; Chung DW; Davie EW
    Proc Natl Acad Sci U S A; 1999 Sep; 96(20):11189-93. PubMed ID: 10500152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of teniposide on platelet functions in vitro.
    Kubisz P; Seghier F; Dobrotorá M; Stasko J; Cronberg S
    Thromb Res; 1995 Jan; 77(2):145-8. PubMed ID: 7740506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of platelet factor 3 by thrombin generation using a micro-coagulation assay.
    Kirchhof B; Balleisen L
    Thromb Res; 1982 Aug; 27(3):303-10. PubMed ID: 6890246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin-induced platelet factor Va formation in patients with a gray platelet syndrome.
    Baruch D; Lindhout T; Dupuy E; Caen JP
    Thromb Haemost; 1987 Aug; 58(2):768-71. PubMed ID: 2445043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditions influencing platelet lysis.
    Kinlough-Rathbone RL; Chahil AMAR ; Packham MA; Mustard JF
    Lab Invest; 1975 Mar; 32(3):352-8. PubMed ID: 1123914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the clot-promoting activity of human platelets in a one-stage prothrombinase assay.
    Bevers EM; Comfurius P; Hemker HC; Zwaal RF
    Haemostasis; 1982; 12(3):268-74. PubMed ID: 7141305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of coagulation factor V by a platelet protease.
    Kane WH; Mruk JS; Majerus PW
    J Clin Invest; 1982 Nov; 70(5):1092-100. PubMed ID: 6752201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
    Furman MI; Krueger LA; Frelinger AL; Barnard MR; Mascelli MA; Nakada MT; Michelson AD
    Thromb Haemost; 2000 Sep; 84(3):492-8. PubMed ID: 11019977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of phenylbutazone, naproxen and flunixin meglumine on equine platelet aggregation and platelet factor 3 availability in vitro.
    Johnstone IB
    Can J Comp Med; 1983 Apr; 47(2):172-9. PubMed ID: 6883184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of activated human platelets in prothrombin and factor X activation.
    Rosing J; van Rijn JL; Bevers EM; van Dieijen G; Comfurius P; Zwaal RF
    Blood; 1985 Feb; 65(2):319-32. PubMed ID: 3967085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.